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Abstract
Objective: The associations of smoking and body mass index (BMI) with health-related quality of
life (QoL) are not well understood among breast cancer survivors. We examined the QoL of breast
cancer patients by smoking status and BMI (1) to determine if there are differences in physical and
mental component summary (PCS and MCS) scores, (2) to evaluate whether there is an interaction
between smoking and BMI on QoL, (3) to assess smoking pattern changes pre- and post-cancer
diagnosis, and (4) to measure changes of physical and mental health by smoking status.
Methods: In this study, we included 6,756 breast cancer patients from the SEER-MHOS linkage
database (1998-2011) who were 65 to 95 years old (inclusive) and did not present with any other
types of cancer. A multivariate linear regression model was used to measure differences in PCS
and MCS scores in different smoking statuses and BMI categories. A subgroup analysis was
performed among 604 patients who responded to surveys pre- and post-diagnosis. We evaluated
the patients’ smoking behavior changes and assessed their mean PCS and MCS score changes by
their smoking status.
Results: After adjusting for patient demographics, cancer characteristics, and comorbidities,
smoking was significantly associated with reduced PCS and MCS scores in breast cancer patients.
Being underweight, overweight or obese was negatively correlated with physical health, while
being underweight was significantly associated with a lower mental health score. There was no
significant interaction between smoking and BMI on QoL. In our subgroup population, only about
26.2% of the smokers quit after breast cancer diagnosis. In the unadjusted analysis, patients who
quit smoking after cancer diagnosis showed greater physical health deterioration but less mental
health decline compared to patients who continued smoking after diagnosis, or who never smoked.
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Conclusions: Smoking and non-normal BMI were associated with poorer QoL, indicating the need
to support breast cancer patients who wish to quit smoking and pursue a healthy BMI. The results
also suggest that achieving a normal BMI may have greater impact on the mental health of
underweight individuals than on those who are overweight or obese. Almost 73.8% of cancer
patients did not quit smoking after their cancer diagnosis, indicating a need for encouraging
smoking cessation among breast cancer survivors.
Keywords: breast cancer; smoking; BMI; smoking patterns; cancer diagnosis; quality of life
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Introduction
Breast cancer is the most commonly diagnosed cancer among women, and it is also the
leading cause of cancer mortality in women worldwide (Parkin & Fernandez, 2006). Globally,
there are an estimated 4.4 million women living with breast cancer who are within 5 years of their
diagnosis (Parkin, Bray, Ferlay, & Pisani, 2005). Breast cancer incidence increases with age in
women. The risk is low before the age of 30 (25 in 100,000), then it shows a linear increase and
peaks and plateaus at 80 (around 500 in 100,000) (Kartal, Tezcan, & Canda, 2013). Twenty one
percent of the 207,000 new invasive breast cancers (43,000) were predicted to be in women aged
75 or older in 2010 (Muss & Busby-Whitehead, 2011). Medical advances and technology progress
have reduced overall mortality and increased human life-span (Cutler & McClellan, 2001). The
rising life expectancy is increasing the number and proportion of elderly people, meaning the 65and-over population is growing consistently (Cutler & McClellan, 2001). In 2012, the estimated
number of the population aged 65 and over was 43.1 million, and this number will almost double
by 2050, to 83.7 million (Ortman & Velkoff, 2014). Given the aging of the US population, it is
important to improve the current health and future health outcomes of the elderly. A breast cancer
survivor at the age of 65 or 75 years can be expected to live an additional 20 or 13 more years,
respectively, if they do not die from breast cancer (Muss & Busby-Whitehead, 2011).
Smoking is associated with reduced effectiveness of cancer treatment and an increased risk
of secondary cancer (Giovino, 2007). Furthermore, prior research indicates that smoking has a
negative impact on the QoL of cancer survivors (National Cancer Institute, 2014), although the
exact mechanisms are unclear. Smoking is associated with many other chronic diseases and
depression (Stafford, Berk, & Jackson, 2013). Almost 50% of the women with early stage breast
cancer had depression or anxiety (Burgess et al., 2005). In addition, smoking contributes to poor
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physical function in elderly women (Nelson, Nevitt, Scott, Stone, & Cummings, 1994). Breast
cancer patients who are current longtime smokers have worse prognosis than non-smokers, but
those who quit after diagnosis do not (Ahmad Kiadaliri, Bastani, & Ibrahimipour, 2012). While
smoking negatively impacts the QoL of patients with smoking-related cancers, whether smoking
is associated with decreased QoL of breast cancer patients is under debate. In a recent study,
although smoking negatively affected cognitive functioning of breast cancer patients and
decreased their survival, there was a lack of evidence that smoking was associated with poor
emotional or physical health in these patients (Ahmad Kiadaliri et al., 2012). Smoking also leads
to various chronic conditions in older adults, and these conditions always cause pain and loss of
function, decrease QoL, and increase costs for health care and long-term care (Centers for Disease
Control and Prevention, 2009). It has been reported that people with smoking-related cancers are
more likely to stop smoking or make serious efforts to quit at the time of diagnosis (Gritz,
Nisenbaum, Elashoff, & Holmes, 1991; Ostroff et al., 1995). However, the overall smoking rates
were similar between female cancer survivors and women who do not have cancer (Mayer &
Carlson, 2011). Taken together, the current literature regarding the impact of smoking on the QoL
of breast cancer survivors is limited.
BMI has long been linked to QoL (Finkelstein, 2000). A higher BMI was associated with
poor QoL among survivors of uterine cancer and endometrial cancer (Fader, Frasure, Gil, Berger,
& von Gruenigen, 2011; Lin, Brown, Segal, & Schmitz, 2014), as well as decreased overall
survival in prostate cancer patients receiving radiotherapy (Smyth, 2015). BMI impacts physical
function, which, in turn, influences mood. Previous research shows that obese or overweight
women are more likely to have anxiety, depression and lower well-being (Jorm et al., 2003). Little
is known about whether such associations exist within breast cancer survivors.
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Prior literature has demonstrated a strong relationship between smoking and BMI (Sneve
& Jorde, 2008). However, research examining how smoking and BMI influence the QoL of elderly
breast cancer survivors is limited. Understanding whether there is a synergetic effect of smoking
and BMI on QoL has the potential to provide valuable information to policymakers, healthcare
providers, and patients and their families, possibly leading to effective interventions that allow
patients to live longer with a higher QoL.
The objective of this study is to assess self-reported QoL among 65 to 95 year-old
Medicare-enrolled breast cancer patients by smoking status and BMI, and to evaluate whether
there is an interaction between smoking and BMI on QoL. We also aim to assess smoking patterns
and behavior changes of breast cancer patients before and after diagnosis and measure the changes
in their physical health and mental health according to their smoking status.

Methods
Data Source
We used linked data from the Center of Medicare and Medicaid Services (CMS) Medicare
Health Outcomes Survey (MHOS) and the National Cancer Institute’s Surveillance, Epidemiology
and End Results (SEER) program. The SEER program includes nearly 28% of the US population
and provides authoritative data on cancer incidence and survival in the US. Out of the 18
population-based cancer registries affiliated with SEER, 14 participated in the SEER-MHOS
linkage. The MHOS was designed as an ongoing, 2-year longitudinal cohort survey of Medicare
beneﬁciaries enrolled in managed-care plans nationwide, starting in 1998 (Ambs et al., 2008), and
it included more than 400 Medicare Advantage managed-care plans (National Cancer Institute,

8

RUNNING HEAD: SMOKING, BMI, AND QOL

2015). The survey was administered to a random sample of 1,000 Medicare beneficiaries from
each managed care plan under contract with CMS. It was designed to measure the health status
and outcomes within each participating Medicare + Choice (M+C) managed care plan in order to
provide risk-adjusted measures of plan performance as well as to assess population-based
outcomes of care (Stevic et al., 2000). The current linked SEER-MHOS database includes twelve
cohorts of MHOS data (baseline and follow up) collected between 1998 and 2011.

Study Sample
A total of 20,021 female breast cancer patients were initially identified by the SEER
program from 1998 – 2011. Of these patients, we first selected 10,165 between the ages of 65 and
95 years (inclusive) who did not present with any other types of cancer. We then excluded 3,409
patients for missing one or more of the following covariates: smoking status, age, race, education,
marital status, region, high blood pressure, heart disease, stroke, chronic obstructive pulmonary
disease (COPD), gastrointestinal (GI) disease, arthritis, diabetes, vision problems, hearing
problems, or time since diagnosis. As a result, the final sample size for this study was 6,756
(Figure 1).

Variables of Interest
Dependent variables
QoL was assessed by PCS and MCS scores using validated measures of SF-12, which is a
12-item questionnaire measuring physical and mental health. As one of the most widely used
instruments for assessing QoL (Nachar et al., 2013), SF-12 evaluates eight dimensions of health
9
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(physical functioning, role physical, bodily pain, general health, vitality, social functioning, role
emotional, and mental health). PCS and MCS summary scores are standardized and normalized to
the US general population and scaled from 0 to 100. The mean score is 50 and the standard
deviation is 10. A higher PCS or MCS score represents better QoL in physical health or mental
health, respectively (Boele et al., 2015). This standard-based scoring makes it possible to interpret
scores by comparing them to those of a reference population.

Independent variables
The primary independent variables of this study were smoking status (smokers or nonsmokers) and BMI. BMI was categorized into 5 categories: underweight (BMI<18.5), normal
(18.5≤BMI<25), overweight (25≤BMI<30), obese (BMI≥30), and unknown. We additionally
examined cancer specific variables including time since cancer diagnosis (<2 years, 3-5 years, 610 years, ≥11 years), breast cancer stage (Stage 0, Stage 1, Stage 2, Stage 3, Stage 4, unknown),
and surgical treatment (breast-conserving surgery (BCS) only, BCS and radiotherapy, mastectomy
with or without radiotherapy, unknown). The non-cancer specific variables we examined were:
age (65 to <70, 70 to <75, 75 to <80, 80 to <85, 85 to <90, 90 to ≤95), race (white, black, other
race), region (Northeast, Midwest, South, West), education level (less than high school, high
school, college or higher education), household income (<$30,000, $30,000 to <$50,000, $50,000
to <$100,000, ≥100,000, unknown), marital status (married, widowed, divorced/separated, never
married), and medical comorbidity (including high blood pressure, heart disease, stroke, COPD,
GI disease, arthritis, diabetes, vision problems, and hearing problems).
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Statistical Analysis
The baseline characteristics of the subjects were summarized using mean (SD) for
continuous variables, and N (proportion) for categorical variables. We used chi-square tests to
compare baseline categorical characteristics and t-tests to compare baseline continuous variables
between breast cancer patients who were smokers and those who were non-smokers. To study the
association between smoking status and QoL (PCS and MCS), multivariate linear regression
models adjusted for the baseline variables mentioned above were used. We also examined whether
adding interaction terms between smoking and BMI affected PCS and MCS scores, and the results
were presented as the least squares mean ± SD of PCS and MCS scores with p values. Statistical
significance was considered at p <0.05.
In order to understand whether smoking patterns had changed due to breast cancer
diagnosis, we created a subgroup including patients who had responded to surveys both before and
after cancer diagnosis and obtained data on their smoking behaviors from both surveys. The
surveys they took closest to their diagnosis dates were the ones used for analysis. Patients included
in this subgroup analysis were divided into 4 categories: (1) smoker both before and after diagnosis
(smokers); (2) smoker before diagnosis but non-smoker after diagnosis (quitters); (3) non-smoker
before diagnosis but smoker after diagnosis (starters); (4) non-smoker both before and after
diagnosis (non-smokers). Furthermore, we assessed the PCS and MCS scores of these 4 groups
of patients based on their pre- and post-diagnosis surveys. Because only very few non-smokers
would be expected to start smoking after diagnosis, we combined starters and non-smokers into
one group as non-smokers. Smokers, quitters, and non-smokers are the ones in which we are most
interested. Therefore, the changes in PCS and MCS scores before and after cancer diagnosis of
these 3 groups were plotted in 2 graphs.
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All analyses were performed by using SAS (version 9.3, the SAS Institute, Cary, North
Carolina).

Results
Patient Characteristics
Among the 6,756 breast cancer patients who had been diagnosed from 1998 to 2011 and
had responded to surveys after cancer diagnosis, 619 were smokers and 6,137 were non-smokers
(Table 1). Smokers were more likely to be underweight and less likely to be overweight or obese
compared to nonsmokers (2.6%, 14.1%, and 6.5% of smokers vs. 1.5%, 17.4%, and 14.3% of nonsmokers). Smokers had worse PCS and MCS scores compared to non-smokers (37.1 and 50.1 vs.
38.2 and 51.6, respectively). The mean age of smokers was younger than that of non-smokers (73.8
vs. 76.3, p<0.001). Smokers had a lower proportion of 85-to-<95 year-olds than non-smokers (4.4%
vs. 11.6%). Education level was lower in smokers compared to non-smokers (35.1% vs. 42.2%
received a college education or higher). Compared to non-smokers, smokers were more likely to
have lower household income, be unmarried, and have a shorter time since diagnosis. There was
no significant difference in race, region, cancer stage or surgical treatment between smokers and
non-smokers. A lower percentage of smokers had high blood pressure, arthritis, and diabetes
compared to non-smokers. However, the proportion of individuals who had COPD in the smoker
group was approximately twice that of the non-smoker group (24.23% vs 12.99%). The
distributions of heart disease, stroke, GI disease, vision, and hearing problems were very similar
in the two groups.
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Factors Associated with PCS and MCS
In multivariate analyses, smoking status and BMI were significantly associated with PCS
and MCS scores in patients who had responded to surveys after breast cancer diagnosis, controlling
for other covariates mentioned above (Table 2). The PCS score and MCS score were 2.02 units
and 1.10 units lower, on average, in smokers compared with non-smokers (p<0.001 and p=0.013,
respectively). In contrast to normal weight patients, individuals who were underweight,
overweight, obese, or who had an unknown BMI had worse physical health. The underweight,
overweight, and obese groups had 3.08, 1.55, and 4.83 lower PCS average scores respectively than
the normal weight group. Underweight patients had MCS scores that were 3.43 units lower on
average compared to normal weight individuals. Overweight and obese individuals had similar
MCS scores to normal weight patients. People living in the South and the West showed
significantly lower PCS scores than those residing in the Northeast. A higher level of education or
household income was associated with better physical and mental health in the study population.
Never married patients demonstrated greater PCS and MCS scores compared to married people.
Physical function was better among those who were diagnosed 11 years or more prior to the survey
compared to those who were diagnosed less than 2 years ago. However, race and surgical treatment
did not appear to be associated with QoL in breast cancer patients.
We also examined whether there were interactions between smoking status and BMI on
the physical health and mental health of breast cancer patients. The results were not statistically
significant (p>0.05).
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Subgroup Analysis
In the subgroup of 604 breast cancer patients who responded to pre- and post-diagnosis
surveys, 61 were smokers and 543 were non-smokers before cancer diagnosis. After cancer
diagnosis, 16 out of 61 had quit smoking, and 6 out of 543 had started smoking. Other people
maintained their smoking behavior after diagnosis (Table 3).
Among 602 patients who reported their PCS scores before and after cancer diagnosis, the
unadjusted average PCS scores for the smokers, quitters, and non-smokers were 42.51, 41.98, and
40.04 prior to diagnosis, and 39.74, 33.88, and 37.10 after diagnosis, respectively (Figure 2). The
unadjusted average MCS scores for smokers, quitters, and non-smokers were 52.50, 52.88, and
52.85 prior to diagnosis, and 49.26, 52.04, and 50.90 after diagnosis, respectively (Figure 3).

Discussion
The results of this study indicate that smoking was significantly associated with poor selfreported physical and mental health in breast cancer survivors, after controlling for patient
demographics, breast cancer-related characteristics, and comorbidities. The study provides
evidence that smoking negatively impacts the health of breast cancer survivors, although smoking
is not considered an important risk factor for breast cancer incidence (Roddam et al., 2007).
Our results showed that non-normal BMI was linked to decreased health outcomes of breast
cancer patients. When evaluating BMI-related health outcomes in breast cancer patients, we
controlled for smoking and other demographic, geographic and clinical characteristics. This, to
our knowledge, has rarely been performed in previous studies (Wong, Lo, Wong, & Fung, 2013).
Both physical and mental health were significantly worse in the underweight group than in the
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normal weight group. Overweight and obese individuals had significantly lower PCS scores in
contrast to normal weight people measured by SF-12, but their MCS scores were not significantly
different. These findings might be explained by the effects of BMI on the physiological function
of body systems, body structures and functional mobility. An abnormally high BMI would reduce
postural control and stability during walking, increase weight exertion on the knee, decrease
neurocognitive function, and cause chronic pain (Forhan & Gill, 2013). Overweight and obese
additionally impacts patients’ physical health by slowing walking speed and limiting adaptability
and mobility. An increased risk of depression from being overweight or obese indicated by
previous studies was not observed in breast cancer patients (Luppino et al., 2010). The physical
functional limitation of underweight individuals may be caused by a smaller amount of muscle
mass leading to lower muscle strength (Ahmed & Haboubi, 2010; Kikafunda & Lukwago, 2005;
Sergi et al., 2007) and reduced physical activity (Sergi et al., 2007). Mental health impairment in
underweight female cancer patients can be caused by reduced consumption of certain types of
nutrients that are helpful in preventing depressive symptoms (Crisp & McGuiness, 1976; Crisp,
Queenan, Sittampaln, & Harris, 1980). It is also possible that dietary patterns such as periodic
eating protect against depression, anxiety and stress (Crisp & McGuiness, 1976; Crisp et al., 1980).
On the other hand, mental health disorders may bi-directionally cause or aggravate body weight
loss through anorexia nervosa (Crisp & McGuiness, 1976; Crisp et al., 1980). Therefore, being
underweight is closely related to negative emotional health outcomes.
There were 604 patients in total who had indicated their smoking status in surveys pre- and
post-diagnosis, and 26.2% smokers quit smoking after they were diagnosed with breast cancer (16
out of 61). In order to assess how physical and mental health changed after cancer diagnosis in
patients with different smoking statuses, their PCS and MCS scores before and after diagnosis
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were compared. The pre-cancer diagnosis PCS scores were 42.51, 41.98, and 40.04 for the smokers,
quitters, and non-smokers respectively. At baseline, the smoking group had the best physical health,
while the non-smokers had the worst. After cancer diagnosis, the quitters had a much greater
decrease of PCS scores compared to the smokers and non-smokers (8.10 vs 2.77 and 2.94). The
unadjusted analysis showed that quitting smoking negatively affected the physical health of breast
cancer patients. However, those patients who quit smoking might have had worse health compared
to others, which forced them to stop smoking. The MCS scores were very similar across these
three groups of people before cancer diagnosis. After cancer diagnosis, quitters had the lowest
decrease of MCS scores (0.84), while smokers had the highest decrease (3.24). Therefore, smoking
cessation probably had beneficial effects on preventing or reducing depression, anxiety, and stress
caused by breast cancer. The effect size could be larger in patients with psychiatric disorders
(Taylor et al., 2014). Through subgroup analysis, we found that smoking cessation was protective
for mental health after cancer diagnosis in breast cancer patients. Therefore, it might be helpful to
encourage smoking cessation in breast cancer patients to promote mental health. Further research
on smoking cessation and physical health should be conducted, as our finding regarding physical
health appeared counterintuitive.
Major strengths of the current study include a population-based study design, a clearlydefined target population (only primarily diagnosed breast cancer patients), and comprehensive
covariate adjustment. The population-based study design enhances the validity and
generalizability of the findings (Sorlie & Wei, 2011). Our target study population was breast
cancer patients without any other types of cancer. This prevented the possible effects of other
cancers on patients’ health. In order to accurately measure the association between smoking status,
BMI and QoL, detailed demographic information, geographic variables, and clinical factors were
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adjusted in the regression models. In addition, our study provided novel data regarding changes in
smoking patterns among breast cancer patients after diagnosis, which had not been evaluated in
previous studies. The analysis of the changes in PCS and MCS scores among the smokers, quitters,
and non-smokers sheds lights on how physical and mental health might be related to smoking
status.
This study also has several limitations. The analysis of cross-sectional data makes it
difficult to assess the temporal relationship of different variables. Some of the data were obtained
from self-reported surveys and could be subject to information bias. Some patients had missing
data on BMI, household income, and cancer stage, reducing the statistical power and possibly even
affecting the validity of the results. In addition, we only categorized smoking status based on
cigarette use at the time of the survey. Among the non-smokers, it is possible that those who never
smoked in their lifetime may have different PCS and MCS scores than former smokers.
Furthermore, although our overall sample size was rather large, the power for some of the analyses,
such as the analysis of potential interactions between smoking status and BMI, might have been
limited.
In the subgroup analysis, only 16 patients quit smoking after breast cancer diagnosis. The
small sample size might have led to difficulty in measuring the changes in PCS and MCS scores
after diagnosis. In addition, changes in physical and mental health pre- and post-diagnosis were
assessed without adjusting for other covariates. Therefore, the negative effects of smoking
cessation on PCS scores could have been influenced by other factors. It is possible that quitters
had more severe cancer progression (Stage 3 or Stage 4) compared to other groups of patients.
Other factors such as socioeconomic status and comorbidity also could have contributed to the
observed associations. For each patient, we only used two surveys that were taken around the date
17
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of diagnosis (before and after). Analyzing longitudinal data over an extended period of time and
analyzing a larger sample would be helpful in understanding how smoking cessation affects breast
cancer patients’ health in the long term.
Future research should focus on identifying the optimal strategies for supporting those who
would like to quit smoking and those who hope to maintain a healthy BMI in order to achieve
positive health outcomes in the long term. Prospective studies designed to better understand the
QoL of breast cancer patients are desired. Healthcare providers and policy-makers should pay
attention to the effects of smoking and BMI on the QoL of breast cancer patients, and seek the best
ways to communicate such information to patients.

Conclusions
In this study, smoking and BMI were significantly associated with the QoL of breast cancer
patients. Cigarette smoking was related to lower PCS and MCS scores. Being underweight,
overweight or obese was negatively correlated with physical health, while being underweight was
significantly associated with poorer mental health. Only a small proportion of breast cancer
patients (26.2%) stopped smoking after cancer diagnosis. Greater efforts need to be made to inform
patients about the harmful effects of smoking and help them quit early.
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Figures and Tables
Figure 1. Study Flow Diagram:
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Figure 2. PCS Change by Smoking Status
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Figure 3. MCS Change by Smoking Status
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Table 1. Characteristics of 6,756 Breast Cancer Patients Diagnosed between 1998 and 2011,
by Smoking Status
Smoking Status

P value

Smoker
(N=619)

Non-smoker
(N=6137)

PCS (SD)a

37.1 (11.9)

38.2 (12.1)

0.039

MCS (SD)b

50.1 (10.8)

51.6 (10.9)

0.001
<0.001

BMI
Underweight

16

2.6

91

1.5

Normal

98

15.8

1250

20.4

Overweight

87

14.1

1067

17.4

Obese

40

6.5

875

14.3

Unknown

378

61.1

2854

46.5

Demographics
Mean Age (SD)

73.8 (5.6)

76.3 (6.7)

<0.001

Age
65-<70

186

30.1

1291

21.0

70-<75

208

33.6

1600

26.1

75-<80

143

23.1

1494

24.3

80-<85

55
27

8.9
4.4

1041
711

17.0
11.6

85-<95

<0.001

0.100

Race
White

517

83.5

5008

81.6

Black

42

6.8

362

5.9

Other

60

9.7

767

12.5
0.271

Region
Northeast

88

14.2

866

14.1

Midwest

62

10.0

604

9.8

South

97

15.7

796

13.0

West

372

60.1

3871

63.1
0.002

Education
Less than high school

138

22.3

1272

20.7

High School

264

42.7

2276

37.1
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Smoking Status
Smoker
(N=619)
College or higher

217

35.1

P value

Non-smoker
(N=6137)
2589

42.2
<0.001

Income
<30K

370

59.8

2999

48.9

30K-<50K

92

14.9

1088

17.7

50K-<100K

31

5.0

609

9.9

≥100K

10

1.6

135

2.2

Unknown

116

18.7

1306

21.3
<0.001

Marital Status
Married

212

34.3

2751

44.8

Widowed

254

41.0

2462

40.1

Divorced/Separated

139

22.5

733

11.9

Never Married

14

2.3

191

3.1

Clinical factors
0.081

Surgical Treatment
BCS only

23

3.7

203

3.3

BCS and Radiotherapy

73

11.8

631

10.3

Mastectomy with/without
Radiotherapy

155

25.0

1333

21.7

Unknown

368

59.5

3970

64.7
0.450

Stage
Stage 0

71

11.5

651

10.6

Stage 1

170

27.5

1720

28.0

Stage 2
Stage 3 & 4

108
11

17.5
1.8

907
94

14.8
1.5

Unknown

259

41.8

2765

45.1
0.001

High Blood Pressure
No

262

42.3

2195

35.8

Yes

357

57.7

3942

64.2
0.093

Heart Disease
No

451

72.9

4272

69.6

Yes

168

27.1

1865

30.4
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Smoking Status
Smoker
(N=619)

P value

Non-smoker
(N=6137)
0.300

Stroke
No

565

91.3

5673

92.4

Yes

54

8.7

464

7.6
<0.001

COPD
No

469

75.8

5340

87.0

Yes

150

24.2

797

13.0
0.583

GI Disease
No

585

94.5

5831

95.0

Yes

34

5.5

306

5.0
0.003

Arthritis
No

250

40.4

2111

34.4

Yes

369

59.6

4026

65.6
<0.001

Diabetes
No

528

85.3

4863

79.2

Yes

91

14.7

1274

20.8
0.807

Vision Problem
No

578

93.4

5746

93.6

Yes

41

6.6

391

6.4
0.132

Hearing Problem
No

565

91.3

5482

89.3

Yes

54

8.7

655

10.7
0.049

Time since Diagnosis
<2 years

128

20.7

1320

21.5

3-5 years

183

29.6

1560

25.4

6-10 years

154

24.9

1463

23.8

≥11 years

154

24.9

1794

29.2

a

For the PCS, N = 6,754.

b

For the MCS, N = 6,726.
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Table 2. Multivariate linear regression models predicting the Physical (PCS) and Mental
(MCS) Component Summary scores among persons with breast cancer

Characteristic
Smoking status
Non-smoker
Smoker
BMI
Normal weight
Underweight
Overweight
Obese
Unknown
Age (years)
65-<70
70-<75
75-<80
80-<85
85-<90
90-<85
Race/ethnicity
White
Black
Other
Region
Northeast
Midwest
South
West
Educational level (years)
Less than high school
High school
College or higher
Income
<30K
30K-<50K
50K-<100K
≥100K
Unknown
Marital status
Married
Widowed
Divorced/Separated
Never Married
Surgical Treatment
BCS
BCS + radiotherapy
Mastectomy +/radiotherapy

PCS (N=6,754)
Score (SE)
p

MCS (N=6,726)
Score (SE)
p

Reference
-2.015 (0.443)

--<0.001

Reference
-1.098 (0.442)

--0.013

Reference
-3.076 (1.036)
-1.553 (0.416)
-4.834 (0.456)
-2.582 (0.354)

--0.003
<0.001
<0.001
<0.001

Reference
-3.425 (1.030)
0.280 (0.414)
0.658 (0.454)
-0.785 (0.353)

--0.001
0.498
0.147
0.026

Reference
-1.225 (0.362)
-2.849 (0.380)
-5.652 (0.434)
-6.463 (0.546)
-8.533 (0.856)

--0.001
<0.001
<0.001
<0.001
<0.001

Reference
-0.102 (0.361)
-0.201 (0.378)
-0.453 (0.432)
-0.922 (0.545)
-1.466 (0.855)

--0.777
0.595
0.295
0.091
0.086

Reference
-0.077 (0.555)
0.221 (0.399)

--0.890
0.579

Reference
-0.048 (0.554)
0.020 (0.397)

--0.930
0.960

Reference
-0.870 (0.525)
-1.414 (0.486)
-1.494 (0.385)

--0.098
0.004
<0.001

Reference
1.256 (0.523)
-0.222 (0.484)
0.450 (0.385)

--0.016
0.647
0.242

Reference
0.960 (0.348)
2.146 (0.361)

--0.006
<0.001

Reference
2.815 (0.347)
3.770 (0.360)

--<0.001
<0.001

Reference
0.626 (0.367)
2.018 (0.468)
2.218 (0.888)
0.372 (0.328)

--0.088
<0.001
0.013
0.257

Reference
0.827 (0.365)
1.866 (0.467)
2.339 (0.883)
0.643 (0.327)

--0.024
<0.001
0.008
0.049

Reference
0.492 (0.301)
0.151 (0.409)
1.708 (0.748)

--0.102
0.713
0.023

Reference
-0.089(0.300)
-0.514 (0.407)
1.447 (0.746)

--0.768
0.207
0.052

Reference
0.492 (0.791)

--0.534

Reference
0.799 (0.789)

--0.311

-0.876 (0.744)

0.239

0.650 (0.743)

0.381
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Unknown
Stage
0
1
2
3
4
Unknown
High blood pressure
Yes
No
Heart disease
Yes
No
Stroke
Yes
No
COPD
Yes
No
GI disease
Yes
No
Arthritis
Yes
No
Diabetes
Yes
No
Vision
Yes
No
Hearing
Yes
No
Time since diagnosis
(years)
<2
3-5
6-10
≥11

-0.507 (0.730)

0.487

0.570 (0.730)

0.435

Reference
-0.971 (0.452)
-1.877 (0.503)
-2.309 (1.213)
-9.130 (2.087)
-1.270 (0.436)

--0.032
<0.001
0.057
<0.001
0.004

Reference
-1.094 (0.451)
-1.148 (0.501)
-2.063 (1.206)
-1.614 (2.075)
-1.068 (0.435)

--0.015
0.022
0.087
0.437
0.014

-2.283 (0.274)
Reference

<0.001
---

-0.711 (0.273)
Reference

<0.001
---

-3.646 (0.283)
Reference

<0.001
---

-1.513 (0.282)
Reference

<0.001
---

-3.846 (0.483)
Reference

<0.001
---

-2.905 (0.481)
Reference

<0.001
---

-3.942 (0.366)
Reference

<0.001
---

-1.980 (0.365)
Reference

<0.001
---

-2.292 (0.576)
Reference

<0.001
---

-4.024 (0.576)
Reference

<0.001
---

-5.894 (0.268)
Reference

<0.001
---

-2.290 (0.266)
Reference

<0.001
---

-2.659 (0.326)
Reference

<0.001
---

-1.482 (0.325)
Reference

<0.001
---

-3.627 (0.528)
Reference

<0.001
---

-5.237 (0.530)
Reference

<0.001
---

-1.504 (0.419)
Reference

<0.001
---

-2.693 (0.418)
Reference

<0.001
---

Reference
0.207 (0.371)
0.635 (0.398)
0.910 (0.459)

--0.577
0.111
0.048

Reference
0.069 (0.370)
0.572 (0.396)
0.366 (0.458)

--0.852
0.149
0.424
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Table 3. Distribution of Subjects by Smoking Status Pre- and Post-Cancer Diagnosis
Survey after diagnosis
Survey before
diagnosis

Smoker
Non-smoker
Total

Smoker
45
6
51

31

Non-smoker
16
537
553

Total
61
543
604

